No headlines found.
No press releases found.
No news found.
Bristol-Myers Squibb Company Celegne Contingent Value Rights trades on the stock market under the symbol CELG^.
As of September 2, 2026, CELG^ stock price climbed to $0.15 with 60,034 million shares trading.
CELG^ has a beta of 2.02, meaning it tends to be more sensitive to market movements. CELG^ has a correlation of 0.02 to the broad based SPY ETF.
CELG^ has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, CELG^ traded as high as $.27 and as low as $.02.
CELG^ has outperformed the market in the last year with a price return of +318.7% while the SPY ETF gained +20.7%. CELG^ has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +46.2% and +48.4%, respectively, while the SPY returned +1.0% and -0.5%, respectively.
CELG^ support price is $.11 and resistance is $.15 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CELG^ shares will trade within this expected range on the day.
